Dhampur Bio Organics Ltd disclosed that its promoter group entity, Sonitron Limited, acquired 10,000 equity shares in the open market on September 22, 2026. This transaction marks a minor incremental increase in the promoter's holding in the company.

The acquisition was executed under the provisions of Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The intimation was filed with both the BSE and the National Stock Exchange of India by Ashu Rawat, Company Secretary & Compliance Officer of Dhampur Bio Organics.

Shareholding Pattern Shift

Prior to this transaction, Sonitron Limited held 1,15,20,499 equity shares, representing 17.353% of the total share capital. Following the purchase of 10,000 shares, the total holding rose to 1,15,30,499 shares. This adjustment increased the promoter's stake to 17.368% of the voting capital.

The disclosure confirms that the acquisition mode was strictly through the open market. There were no changes in encumbered shares, warrants, or convertible securities associated with this specific transaction.

Transaction Details

The target company's total equity share capital remained unchanged at 6,63,87,590 equity shares of ₹10 each before and after the said acquisition. The diluted share capital also remained constant at the same figure, indicating no outstanding convertible instruments affecting the total count during this period.

Sonitron Limited is registered as a promoter company within the promoter group. The director of Sonitron Limited, Mukul Sharma, signed the disclosure form submitted to the exchanges. The date of receipt of intimation for the allotment or purchase was recorded as September 24, 2026.

Dhampur Bio Organics Limited’s promoter group entity, Sonitron Limited, acquired a total of 40,000 equity shares in two separate open market transactions during the first week of August 2026. The acquisitions, executed on August 05 and August 06, 2026, increased Sonitron’s aggregate holding to 1,15,20,499 shares, representing 17.353% of the company’s total share and voting capital. The disclosures were filed with the BSE Limited and the National Stock Exchange of India Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Two-Tranche Acquisition Details

Sonitron Limited, headquartered in New Delhi, conducted the purchases across two consecutive trading sessions. Mukul Sharma, Director of Sonitron Limited (DIN: 00078995), signed the disclosure forms dated August 06, 2026, from Mumbai. The first tranche involved the purchase of 25,000 equity shares on August 05, 2026, accounting for 0.038% of the total share capital. The second tranche saw the acquisition of 15,000 equity shares on August 06, 2026, representing 0.022% of the total share capital. Both transactions were carried out through the open market mechanism.

The following table outlines the movement in Sonitron Limited’s shareholding:

Capital Structure and Regulatory Compliance

The equity share capital of Dhampur Bio Organics remained constant at 6,63,87,590 equity shares of ₹10 each throughout both transactions. Consequently, the total diluted share/voting capital also remained unchanged at 6,63,87,590 equity shares. Sonitron Limited confirmed that none of the acquired shares are subject to encumbrance, pledge, lien, or non-disposal undertaking. Furthermore, there are no outstanding warrants or convertible securities held by the acquirer.

The disclosures comply with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which requires promoter group entities to report changes in shareholding upon crossing specified thresholds. Ashu Rawat, Company Secretary & Compliance Officer of Dhampur Bio Organics Limited, intimated the exchanges about the receipt of these disclosures on August 07, 2026.